tiprankstipranks
Trending News
More News >

Cyclerion Therapeutics treatment of mitochondrial disease gets orphan status

Cyclerion Therapeutics’ zagociguat was granted FDA orphan designation as a treatment of mitochondrial disease, according to a post to the agency’s website. Reference Link

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on CYCN:

Disclaimer & DisclosureReport an Issue

1